Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide

Allergic pruritus and peripheral neuropathy : 2 case reports

    This is a preview of subscription content, log in to check access.

    References

    1. 1.

      Eron J, et al. Safety and efficacy of elvitegravir/cobicistat/emtricitabine/ tenofovir alafenamide (E/C/F/TAF) in HIV-infected adults on chronic haemodialysis. HIV Medicine 19 (Suppl. 2): S16 (plus oral presentation) abstr. 035, Apr 2018. Available from: URL: https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.12613

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide. Reactions Weekly 1791, 76 (2020). https://doi.org/10.1007/s40278-020-74921-6

    Download citation